Program | XII Spanish-Portuguese Conference on Controlled Drug Delivery

14/01/2018
14.00-16.00	Registration and setting up the posters
16.00	Welcome Session João Nuno Moreira (CNC/UC, FFUC, President of the SPLC-CRS), Luís Menezes (Vice-Dean of the University of Coimbra), María José Alonso ("President elect" of the Controlled Release Society)
16.15	*Plenary Lecture* Nicholas A Peppas - Protein, Antibody and siRNA Delivery Using Intelligent Polymers with Molecular Recognition Capabilities Sc.D. Cockrell Family Regents Chair in Engineering, Department of Biomedical Engineering, McKetta Department of Chemical Engineering, Department of Pediatrics, Department of Surgery and Perioperative Care, Dell Medical School, Division of Pharmaceutics, College of Pharmacy Director, Institute for Biomaterials, Drug Delivery and Regenerative Medicine The University of Texas at Austin, USA Session Chair - María José Alonso (CIMUS Research Institute, University Santiago de Compostela)
	SESSION 1 - Neurological disorders Session Chair - Alicia Rodriguez Gascón (University of the Basque Country, Vitoria)
17.00	Ana Paula Pêgo - Engineering Nanoparticles to Cargo Nucleic Acids to the Nervous System: Breaking Barriers with Nanotools INEB - Instituto de Engenharia Biomédica and i3S - Instituto de Investigação e Inovação em Saúde, University of Porto
17.30	Elisa Garbayo Atienza - Brain regeneration in Parkinson's disease using micro/nanoparticles Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy, University of Navarra, Spain
18.00	Luís Pereira de Almeida - Non-invasive gene therapy of the brain Center for Neurosciences and Cell Biology; Faculty of Pharmacy, University of Coimbra, Portugal
	SESSION 2 - PhD Thesis Award Session Chair - Dolores Torres (Vice-President of the SPLC-CRS)
18.30	Award Announcement and Thesis Presentation
19.00	Welcome Cocktail: Passaporte - Lounge Terrace, Rua da Couraça Estrela, Coimbra (as in Google Maps).
15/01/2018
09.00	Plenary Lecture Patrick Couvreur - Nanomedicines for the treatment of cancer and neurological disorders Member of the Académie des Sciences, Institut Galien Paris-Sud, UMR CNRS 8612, Université Paris-Sud, Université Paris Saclay, Châtenay- Malabry Cedex, France
	SESSION 3 - Cancer Session Chair - António Almeida (Faculty of Pharmacy, University of Lisbon)
09.45	Davide Prosperi - Impact of ligand moiety on targeting and anti-tumor effect of antibody nanoconjugates Department of Biotechnology and Biosciences, University of Milano Bicocca, Italy
10.15	Maria Jesus Vicent - Towards the Design of Personalised Polymer-based Combination Conjugates for Advanced Stage Breast Cancer Patients Centro de Investigación Príncipe Felipe, Valencia, Spain
10.45	António Duarte - Targeting Notch signaling in mouse tumor models Faculdade de Medicina Veterinária, Universidade de Lisboa
11.15 - 11.45	Coffee-break and Speed Dating with Bluepharma
	SESSION 4 - SPLC-CRS Young Section Session Chair - Simón Pascual-Gil (University of Navarra) and Pedro Fonte (Lusófona University, Lisbon)
11.45 - 13.10	Short Talks Selected from Abstracts * 11.45 - 11.52 - Eugénia Nogueira, *Folate-targeted liposomes for rheumatoid arthritis therapy.* Centre of Biological Engineering, University of Minho, Braga, Portugal. 11.52 - 11-59 - Jacinta Pinho, *Targeting AQP3 using a nanotechnological approach for melanoma treatment.* Research Institute for Medicines, Faculty of Pharmacy, Universidade de Lisboa. 11.59 - 12-06 - Ainhoa Gonzalez-Pujana, *Matrix-mediated gene expression regulation in mesenchymal stem cells immobilized in alginate-poly-L-lysine-alginate microcapsules.* School of Pharmacy, University of the Basque Country, Vitoria 12.06 - 12.13 - Edorta Santos-Vizcaino, *Use of genipin as a quantitative imaging biomarker in implanted immunoisolation devices.* School of Pharmacy, University of the Basque Country, Vitoria. 12.13 - 12.20 - João Conniot, *Combination of Dendritic Cell-targeted Nano-vaccines with Immune Checkpoint Therapy for Melanoma. Research Institute for Medicines, Faculty of Pharmacy, Universidade de Lisboa. 12.20 - 12.27 - Laura Saludas, Enhanced biological functions of adipose derived stem cells in the injured myocardium of a rat myocardial infarction model when combined with neuregulin-loaded microparticles.* Faculty of Pharmacy, University of Navarra, Pamplona. 12.27 - 12.34 - Iago Fernández-Mariño, *Interaction of small and medium size chitosan nanocapsules with different subsets of immune cells.* Center for Research in Molecular Medicine and Chronic Diseases, University of Santiago de Compostela. 12.34 - 12.41 - Duy-Khiet Ho, *Squalenyl Hydrogen Sulfate Nanocarrier for Dual-Delivery of Anti-infective Quorum Sensing Inhibitor and Aminoglycoside Antibiotic Tobramycin.* Helmholtz Institute for Pharmaceutical Research Saarland, Saarbrücken. 12.41 -12.48 - Josephine Blersch, *HT-Screening identifies light triggerable NP formulation for efficient in vivo non-coding RNA delivery in wound healing. Center for Neuroscience and Cell Biology, University of Coimbra. 12.48 - 12.55 - Branca Silva, Orodispersible films to treat a neurodegenerative disorder: clinical proof of concept. Bluepharma Indústria Farmacêutica and Faculty of Pharmacy, University of Coimbra. 12.55-13.02 - Nuno Fonseca, Tumor intracellular bioavailability of doxorubicin determines therapeutic efficacy of GLP grade nanoparticle targeted to nucleolin independently of systemic exposure.* Center for Neuroscience and Cell Biology, University of Coimbra. 13.02 - 13.09 - Patrícia Albuquerque, *Exosomes: tiny vesicles with great potential for MJD treatment.* Center for Neuroscience and Cell Biology, University of Coimbra.
13.10-14.00	Lunch and Speed Dating with Bluepharma
14.00-15.00	SESSION 5 - Poster Discussion **
	SESSION 6 - Regenerative Medicine Session Chair - Gorka Orive Arroyo (University of the Basque Country, Vitoria)
15.00	Lino Ferreira - Drug Delivery in Regenerative Medicine Faculty of Medicine, Center for Neuroscience and Cell Biology, University of Coimbra, Portugal
15.30	Marcos Garcia Fuentes - mRNA-activated reprogramming matrices Center for Research in Molecular Medicine and Chronic Diseases, University of Santiago de Compostela, Spain
16.00	Nuno Neves - Highly Functional Nanostructured Surfaces and Devices for the Development of Effective Tissue Engineering Strategies. 3B’s Research Group - Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Taipas, Guimarães. ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães.
16.30-17.00	Coffee-break and Speed Dating with Bluepharma
	SESSION 7 - Diagnosis / Medical Devices Session Chair - Ana Grenha (Faculdade de Ciências e Tecnologia, Universidade do Algarve)
17.00	Pedro Viana Baptista - Versatile gold nanoparticles for molecular diagnostics in leukemia Departamento de Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa, Campus Caparica, Portugal
17.30	Manuel Arruebo - Near infrared dye-labeled polymeric micro- and nanomaterials: in vivo imaging and evaluation of their local persistence Aragon Nanoscience Institute, University of Zaragoza, Spain
18.00-19.00	SPLC-CRS GENERAL ASSEMBLY
21.00	CONFERENCE DINNER: Quinta das Lágrimas Hotel, Rua António Augusto Gonçalves., Coimbra (as in Google Maps). Buses will be available and will depart from Hotels Tivoli, Tryp Coimbra and IBIS at 8.30 pm.
16/01/2018
	SESSION 8 - Immunotherapy Session Chair - Olga Borges (CNC & Faculty of Pharmacy, University of Coimbra)
09.00	João Gonçalves - Antibody engineering strategies for antiviral neutralization Research Institute for Medicines, iMed.ULisboa, Faculty of Pharmacy, University of Lisbon, Portugal
09.30	Miguel Prudêncio - Towards clinical evaluation of a new malaria vaccine Institute of Molecular Medicine, Faculty of Medicine, University of Lisbon
10.00	Helena Florindo - Enhancing cancer immunotherapy via nanotechnology-based strategies to engage innate and adaptive immune responses Research Institute for Medicines, iMed.ULisboa, Faculty of Pharmacy, University of Lisbon, Portugal
10.30-11.00	Coffee-break and Speed Dating with Blueclinical
	SESSION 9 - *ROUND TABLE - Bridging the Translational Gap Between Academia and the Patient* Session Chair - Rogério Gaspar** Faculty of Pharmacy & Institute for Bioengineering and Biosciences, University of Lisbon, Portugal
11.00-13.00	Laura Alho - Technology Transfer Office, University of Coimbra, Portugal Cláudia Silva - Bluepharma Indústria Farmacêutica SA and Luzitin, SA, Portugal Ricardo Cunha - Blueclinical, Ltd, Portugal. David Cristina - Senior Investment Director, FOSUN.
13.00-13.15	Oral and Poster Communication Prizes Concluding Remarks

* - ORAL COMMUNICATIONS in the SPLC-CRS Young Section, SESSION 4, are strictly limited to 5 min, with 2 min for Q&A

** - POSTER COMMUNICATIONS

The posters selected by the scientific committee will be displayed for all the conference.

Your poster number will appear on the top right hand side of the board so you can locate your board easily.

Please check your poster number in the Abstract Book closer to the conference.

It is appreciated that a photo is shown (on the top of the poster)

Poster Discussion - SESSION 5

Authors are requested to be available for questions during the scheduled poster discussion.

It is desirable to provide takeaway versions of the poster in A4 format.

Poster Guidelines - Poster must have the size of a standard (80cm x 118 cm) in portrait layout .

Abstract Book

New deadlines